| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6109667 | Journal of Hepatology | 2009 | 10 Pages |
Abstract
During telbivudine treatment, non-detectable serum HBV DNA at treatment week 24 is the strongest predictor for optimal outcomes at 2Â years.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Stefan Zeuzem, Edward Gane, Yun-Fan Liaw, Seng G. Lim, Adrian DiBisceglie, Maria Buti, Anuchit Chutaputti, Jens Rasenack, Jinlin Hou, Christopher O'Brien, Tuan T. Nguyen, Jidong Jia, Thierry Poynard, Bruce Belanger, Weibin Bao, Nikolai V. Naoumov,